Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DSGN · against 489 other Healthcare companies of similar size
Ranked #45 of 490 · scores higher than 91% of peers · safety percentile 92
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)55 peers with a safety percentile of 90–100, including DSGN · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | DSGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 458 reported | 0.01× | 0.17× | 86% | 33% | |
| BetaLower is better · 469 reported | 1.66 | 0.42 | 6% | 33% | |
| Current ratioHigher is better · 485 reported | 18.86× | 2.88× | 96% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.2B USD | 100 | 40 | |
| 2 | 1.1B USD | 100 | ||
| 3 | 1.0B USD | 99 | 35 | |
| 4 | 421M USD | 99 | 52 | |
| 5 | 1.2B USD | 99 | ||
| 41 | 4.5B HKD (≈$579M) | 93 | 54 | |
| 42 | 660M USD | 92 | ||
| 43 | 469M USD | 92 | 45 | |
| 44 | 1.2B USD | 92 | 67 | |
| 45 | 647M USD | 92 | 40 | |
| 46 | 705M USD | 92 | 32 | |
| 47 | 815M USD | 91 | 53 | |
| 48 | 891M USD | 91 | ||
| 49 | 968M USD | 91 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score